Table 2.
Treatment | Cholesterol (mg/dL) | Triglycerides (mg/dL) | HDL (mg/dL) | LDL (mg/dL) | VLDL (mg/dL) |
---|---|---|---|---|---|
Control | 89.6 ± 3.03 | 65.9 ± 3.36 | 53.40 ± 2.44 | 23.00 ± 2.44 | 13.19 ± 0.67 |
CCl4 | 200.3 ± 8.63** | 157.1 ± 4.23** | 26.80 ± 1.01* | 142.10 ± 8.69** | 31.43 ± 0.84* |
LSE-250 + CCl4 | 151.5 ± 5.59*## | 129.8 ± 4.26*# | 39.85 ± 2.22## | 86.68 ± 6.81*## | 25.96 ± 0.85*# |
LSE-500 + CCl4 | 123.0 ± 3.72## | 101.4 ± 5.02*## | 42.03 ± 1.45## | 60.68 ± 5.01*## | 20.28 ± 1.00## |
Silymarin-10 + CCl4 | 130.8 ± 6.17## | 131.6 ± 5.05*## | 36.91 ± 1.13## | 67.58 ± 6.48*## | 26.33 ± 1.01*# |
All values represent mean ± SEM. *P < 0.01 and **P < 0.001 verses control; #P < 0.05 and ##P < 0.01 versus CCl4 only group.